גורמי סיכון לתמותה בחולי שבץ הזקוקים להנשמה מכנית

מן הרשת

עמוד 6 מתוך 56
<
1
2
3
4
5
6
7
8
9
10
...
56
>

04.06.2025

12:14

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

We conducted a multinational, phase 3, open-label trial to compare tarlatamab with chemotherapy as second-line treatment in patients with small-cell lung cancer whose disease had progressed during or after platinum-based chemotherapy

NEJM

04.06.2025

12:13

Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer

In this open-label, phase 3 trial, patients with stage IB to IIIA resectable NSCLC were randomly assigned to receive nivolumab plus chemotherapy or chemotherapy alone for three cycles, followed by surgery

NEJM

28.05.2025

13:42

Protective genetic variants against Alzheimer's disease

Genetic studies can offer powerful insights for the development of disease-modifying therapies for Alzheimer's disease

The Lancet Neurology

28.05.2025

13:39

A new characterisation of acute traumatic brain injury

the NIH-NINDS TBI Classification and Nomenclature Initiative

The Lancet Neurology

28.05.2025

13:38

Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease

Objective: To compare individuals who have discrepant biological and clinical stages with those who have congruent stages in terms of copathologies, comorbidities, and demographics

JAMA Neurology

07.04.2025

11:08

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Is the clinical phenotype of patients without dementia associated with blood phosphorylated tau 217 (p-tau 217) interpretation?

JAMA Neurology

06.03.2025

13:05

Non-inferiority design for trials in multiple sclerosis

When effective treatments exist, trials compare new drugs with those standards using either a superiority or non-inferiority design

The Lancet Neurology

06.03.2025

13:04

Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosis

פעילות עצבית במוח. הדמיה

Progress in magnetic resonance imaging (MRI) technology and analyses is improving our comprehension of multiple sclerosis (MS) pathophysiology

Journal of Neurology

06.03.2025

13:01

Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis

We aimed to explore the feasibility of a single, unified set of diagnostic criteria when applied to patients with suspected PPMS

Annals of Neurology

06.03.2025

13:00

Towards a biological view of multiple sclerosis from early subtle to clinical progression

an expert opinion

Journal of Neurology

06.03.2025

12:59

Cancer in multiple sclerosis patients following prolonged exposure to disease-modifying therapies (DMTs)

a systematic review and meta-analysis

Journal of Neurology

06.03.2025

12:58

Multiple sclerosis diagnosis: a biologically driven perspective

Emerging evidence is now challenging this approach and lending support to a redefinition of disease diagnoses based on biology rather than clinical features

The Lancet Neurology

06.03.2025

12:44

Fatigue in multiple sclerosis: can we measure it and can we treat it?

This paper describes the challenges clinicians and researchers face when assessing and treating MS patients, as well as our understanding of neural mechanisms involved in fatigue

Journal of Neurology

06.03.2025

12:40

Treatment discontinuation in older people with multiple sclerosis

The aim of this review was to examine the evidence for disease-modifying therapies (DMTs) discontinuation in older people with multiple sclerosis (MS)

Current Opinion in Neurology

06.03.2025

12:39

Cognitive Impairment in Multiple Sclerosis

טרשת נפוצה (צילום: אילוסטרציה)

Past, Present, and Future

Neuroimaging Clinics of North America

עמוד 6 מתוך 56
<
1
2
3
4
5
6
7
8
9
10
...
56
>